LUNCH & LEARN ~ Advanced Systemic Mastocytosis and the APEX Clinical Trial ~ Tuesday, 12/3/24Nov 24, 20241 min readRegisterHosted by:
NEW Event! From Mutation to Management: Practical Nursing Strategies in HER2-Mutant NSCLC ~ 5.14.26 @ ONS Congress
Management of high-risk non-melanoma skin cancers (NMSC)Dear BONS Membes, I’d like to invite you to join a Dana-Farber–anchored, multidisciplinary CME activity focused on the management of high-risk non-melanoma skin cancers (NMSC)—including BCC, cSCC, and
NEW EVENT! An Approved Trop2-Directed ADC forAdults With Previously Treated HR+/HER2–(IHC 0, IHC 1+ or IHC 2+/ISH–) MetastaticBreast Cancer - May 13th!
Comments